• Japanese
  • Korean
  • Chinese
Cover Image

2015-2019 Emerging Cancer Diagnostic Tests, and Strategic Profile of Leading Suppliers

This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

Table of Contents

Major Current And Emerging Cancer Diagnostic Tests

  • 1. Introduction
  • 2. Tumor Marker Classification
  • 3. ACTH
  • 4. Alpha-Fetoprotein (AFP)
  • 5. Beta-2 Microglobulin
  • 6. CA 15-3/27.29
  • 7. CA 19-9
  • 8. CA-125
  • 9. Calcitonin
  • 10. Carcinoembrionic Antigen (CEA)
  • 11. Estrogen and Progesterone Receptors
  • 12. Ferritin
  • 13. Gastrin
  • 14. Human Chorionic Gonadotropin (HCG)
  • 15. Insulin
  • 16. NSE
  • 17. Occult Blood
  • 18. PAP Smear/HPV
  • 19. Prostatic Acid Phosphatase (PAP)
  • 20. Prostate-Specific Antigen (PSA)
  • 21. Squamous Cell Carcinoma Antigen (SCC)
  • 22. T and B Lymphocytes
  • 23. TdT
  • 24. Thyroglobulin
  • 25. Tissue Polypeptide Antigen (TPA)
  • 26. Biochemical Tumor Markers
  • ADA
  • B-Protein
  • PNP
  • 5'-Nucleotidase

27. Oncogenes

  • Abl/abl-bcr
  • AIB1
  • BCL-2
  • BRCA1
  • CD44
  • C-fos
  • C-myb
  • C-myc
  • CYP-17
  • Erb-B
  • HPC1
  • N-myc
  • P40
  • P51
  • P53
  • PIK3CA
  • PTI-1
  • Ras
  • Reg
  • Sis
  • Src

28. Polypeptide Growth Factors

  • Basic Fibroblast Growth Factor
  • Beta-TGF
  • Cachectin (TNT)
  • Calmodulin
  • ECFR
  • Nerve Growth Factor (NGF)
  • Epidermal Growth Factor (EGF)
  • Ornithine Decarboxylase
  • Transferrin
  • Transforming Growth Factor-Alpha

29. Ectopic Hormones

30. Colony Stimulating Factors

31. Lymphokines

  • Alpha-Interferon
  • B Cell Growth Factors
  • B Cell Growth Factor (BCGF)
  • Gamma-Interferon
  • Interleukin-1 (IL-1)
  • Macrophage Activating Factor

32. Immunohistochemical Stains

33. Emerging Tumor Markers

  • N-Acetylglucosamine
  • Actin
  • Alpha-Actin
  • Antineuronal Antibodies
  • 7B2
  • B72.3
  • Bax
  • BCD-F9
  • BLCA-4
  • Blood Group Antigens A,B,H
  • CA 50
  • CA 72-4/TAG-72
  • CA 195
  • CA-242
  • CA-549
  • CAM 26
  • CAR-3
  • Cathepsin-D
  • Chromogranin A and B
  • Cluster 1 Antigen
  • Cluster-5/5A Antigen
  • CTA
  • CU18
  • DR-70
  • DU-PAN-2
  • Endometrial Bleeding Associated Factor
  • Endostatin
  • Epithelial Membrane Antigen
  • Feulgen Hydrolysis
  • Fibronectin
  • FSH
  • (1->3)-L-fucosyltransferase
  • Gastrin-Releasing Peptide (GRP)
  • GDCFP-15
  • Glucagon
  • Glycoamines
  • H23
  • Her-2
  • Human Carcinoma Antigen
  • HPA
  • HSP27
  • Intermediate Filaments
  • Cytokeratins/CK18/Cyfra 21-1
  • Desmin
  • Gliofibrillary Acid Protein
  • Neurofilaments
  • Vimentin
  • KA 93
  • Kinases
  • KP16D3
  • LAI
  • Leukocyte Common Antigen
  • Lewis Antigens
  • Lysophosphatidic Acid (LPA)
  • Ma 695/Ma 552
  • MABDF3
  • MAG
  • ME1
  • Minactivin
  • MN/CA9
  • MSA
  • Mucin Cancer Antigen (MCA)
  • Multiple Tumor Suppressor 1
  • Myosin
  • NEA-130
  • NMP22
  • OA-519
  • Opiod Peptides
  • P-glycoprotein
  • Pancreatic Oncofetal Antigen (POA)
  • Placental Lactogen
  • PR92
  • Proliferative Index, Ki-67
  • Px
  • RB Inactivation/Deletion
  • Ret
  • SCCL 175
  • Selectin
  • Sialic Acid
  • Sialyl SSEA-1/SLX
  • SN10
  • Somatostatin
  • TA-90
  • TABA
  • Tachykinin
  • TAG 12
  • TPS
  • Troponin
  • Tubulin
  • VCAM
  • VEGF
  • Villen

Competitive Profiles

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

Appendixes

  • Appendix I: Major Universities and Research
  • Centers Developing Cancer Diagnostic
  • Technology and Applications

List of Tables

  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or MarketingCA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Show More
RELATED REPORTS
* Next-Generation Cancer Diagnostics Market Forecast 2015-2025: Opportunities for Leading Companies Developing Advanced PCR Techniques, CTC tests, FISH tests, Microarrays and NGS Technologies
  • Published:
  • Jul 27, 2015
  • USD 2788
  • 176 Pages

* Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020
  • Published:
  • Jun 10, 2015
  • USD 4650
  • 181 Pages

* Global Cervical Cancer Diagnostic Tests Market 2014-2018
  • Published:
  • Dec 17, 2014
  • USD 2500
  • 103 Pages

* Cervical Cancer Diagnostic Tests Market (Tests (Pap Smear tests, Colposcopy, HPV Testing, Endocervical Curettage & Others (Cone Biopsy & Loop Electrosurgical Excision Procedure): Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014-2020
  • Published:
  • Nov 27, 2014
  • USD 4795
  • 85 Pages

* Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
  • Published:
  • Oct 31, 2014
  • USD 4795
  • 124 Pages

* Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report
  • Published:
  • Jul 28, 2014
  • USD 4500
  • 219 Pages

* The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
  • Published:
  • May 08, 2013
  • USD 3500
  • 670 Pages

* Cancer Diagnostic Testing World Markets
  • Published:
  • May 01, 2013
  • USD 3400
  • 336 Pages

* Global Next Generation Cancer Diagnostic Devices Market 2012-2016
  • Published:
  • Mar 07, 2013
  • USD 2000
  • 35 Pages

* Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy And Ecc Procedures) Market - Global Industry Analysis By Test Type And Age Group, Market Size, Share And Forecast, 2012 - 2018
  • Published:
  • Oct 26, 2012
  • USD 4595
  • 124 Pages

Browse more In Vitro Diagnostics Market Research Reports

Pricing
  • Int'l: +1-860-674-8796
  • TollFree(US): +1-866-353-3335
  • Europe: +32-2-535-7543
  • Asia: +65-6223-2436
Back to Top